Cargando...
Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma
IMPORTANCE OF THE FIELD: The incidence of malignant melanoma is increasing throughout the world and is currently rising faster than any other cancer in men and second only to lung cancer in women. Current strategies focused on systemic therapy for treatment of have shown no effect on survival. There...
Guardado en:
| Publicado en: | Expert Opin Ther Targets |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2010
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4229031/ https://ncbi.nlm.nih.gov/pubmed/20230195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728221003652471 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|